13F-HR filed by Foresite Capital Management IV, LLC
Foresite Capital Management IV, LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-13, with 13 holding rows worth $142,664,000.
- Accession
- 0001144204-18-007694
- Filer
- CIK 1704132
- Filed
- 2018-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2017
A holdings report, 13 entries on the cover page, a total value of $142,664,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $142,664,000 with VALUE read as thousands by filing date, 13F file number 028-18415. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INSMED INC COM PAR $.01 | 457669307 | Stock | 879,910 | $27,436,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 529,343 | $21,205,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 2,254,502 | $20,741,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,073,272 | $17,344,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 309,357 | $13,024,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 635,234 | $12,444,000 | thousands by filing date | |
| OPTINOSE INC | 68404V100 | COM | 450,000 | $8,505,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 251,936 | $6,213,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 213,435 | $5,758,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 175,000 | $5,086,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 232,909 | $2,667,000 | thousands by filing date | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 94,666 | $1,481,000 | thousands by filing date | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 150,592 | $760,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-18-007694 | this filing | 2018-02-13 | acceptance time not in the bulk data set |